Global Microneedle Flu Vaccine Market- Driver
Increasing prevalence of influenza
The increasing prevalence of influenza which requires microneedle flu vaccines for its treatment is expected to drive the market growth over the forecast period. For instance, in October 2022, a report published on WebMD LLC., a full-service Internet healthcare portal, stated that an estimated 5,000 to 14,000 deaths have been attributed to influenza since October 2021.
Increasing launch of new flu prevention campaigns and initiatives by healthcare organizations
The launch of new flu prevention campaigns and initiatives by healthcare organizations is expected to drive demand for influenza vaccines and develop effective vaccination delivery systems. For instance, in October 2021, The Centers for Disease Control and Prevention (CDC) and the National Foundation for Infectious Diseases (NFID), along with other public health and medical organizations, jointly announced the opening of the 2020-2021 flu vaccination season, highlighting the importance of vaccination and recommending that everyone six months and older get vaccinated against flu once a year.
Global Microneedle Flu Vaccine Market: Restraint
The disadvantages of the microneedle flu vaccine
The major factors that can hamper the growth of the global microneedle flu vaccine market over the forecast period include disadvantages like it is time-consuming, it may result in scarring of the skin, etc. For instance, in December 2022, The American Society for Microbiology, an open-access journal, published an article stating that the amount of time it takes to dissolve a microneedle may range from minutes to several hours, which is a major disadvantage of using microneedles.
Therefore, overcoming the disadvantages associated with the use of microneedle flu vaccines may help in increasing the wider application of microneedle flu vaccines and can tackle these restraints.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients